Meta Biomed Co., Ltd (059210) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Meta Biomed Co., Ltd (059210:KRX), powered by AI.

Current Price
₩3,815
P/E Ratio
9.4
Market Cap
103.7B
Sector
Common Stock
What is the Meta Biomed Co., Ltd stock price forecast?

Meta Biomed Co., Ltd is currently trading at ₩3,815. View real-time AI analysis on Alpha Lenz.

What is Meta Biomed Co., Ltd insider trading activity?

View the latest insider trading data for Meta Biomed Co., Ltd on Alpha Lenz.

What is Meta Biomed Co., Ltd's P/E ratio?

Meta Biomed Co., Ltd's P/E ratio is 9.4.

Meta Biomed Co., Ltd

KRX · 059210
₩3,815+65(+1.73%)Market closedKRX regular session 09:00–15:30 KST
Ask about Meta Biomed Co., Ltd's future dividend policy...
Alpha Chat Insight

Meta Biomed Co., Ltd trades at a P/E of 9.4 (undervalued) with solid ROE of 10.1%. 3Y revenue CAGR of 14.3% highlights clear growth momentum.

Ask for details

Company Overview

Meta Biomed Co., Ltd is a biomedical and chemical company that specializes in the research, development, and manufacture of medical and dental materials. The company focuses primarily on biopolymers and bio-solutions aimed at improving human health and quality of life. Its product range includes dental materials such as restorative and endodontic items, surgical sutures, and bone graft materials. By leveraging innovative technologies, Meta Biomed strives to address various medical and dental industry needs, providing high-quality and reliable products to healthcare professionals worldwide. As a notable player in the biomedical sector, Meta Biomed Co., Ltd fits into the broader ecosystem of companies contributing to advancements in healthcare and medical treatments. Through its global distribution network, the company extends its reach, impacting the medical and dental care industries significantly.

CEO오석송
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩103,659,062,675Market Cap
₩102,951,318,550Revenue
27.17MShares Out
0Employees

Margins

52.06%Gross
27.42%EBITDA
20.81%Operating
12.23%Pre-Tax
10.46%Net

Valuation

9.43P/E
0.83P/B
1.01EV/Sales
4.57EV/EBITDA
-165.09P/FCF

Growth (CAGR)

14.30%Rev 3Yr
18.00%Rev 5Yr
58.66%Op Inc 3Yr
51.74%Op Inc 5Yr
44.10%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

5.92%ROA
10.10%ROE
8.49%ROIC

Financial Health

₩17,955,659,470Cash & Cash Equivalents
₩43,774,602,710Net Debt
49.43%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Meta Biomed Co., Ltd (ticker: 059210) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $103.7B.

The current price is ₩3,815 with a P/E ratio of 9.43x and P/B of 0.83x.

ROE is 10.10% and operating margin is 20.81%. Annual revenue is $103.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Meta Biomed Co., Ltd (059210) Stock Forecast 2026 ₩3,815 — Price, Financials & Analyst Targets | Alpha Lenz